NWBO Northwest Biotherapeutics Inc.

Fundamentals / CIK 0001072379 / USD

Northwest Biotherapeutics Inc. reported $2.86M in revenue and a net loss of $39.66M for the trailing twelve months ended September 30, 2026 (up 341.5% year over year), with a -1608.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NWBO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$232.5M$116.2M$0-$510.6MFY 2016 Revenue: $623KFY 2016 Net Income: -$80.21M2016FY 2017 Revenue: $336KFY 2017 Net Income: -$73.14M2017FY 2018 Revenue: $412KFY 2018 Net Income: -$35.79M2018FY 2019 Revenue: $2.41MFY 2019 Net Income: -$20.81M2019FY 2020 Revenue: $1.29MFY 2020 Net Income: -$529.8M2020FY 2021 Revenue: $1.00MFY 2021 Net Income: $179.1M2021FY 2022 Revenue: $1.68MFY 2022 Net Income: -$105.0M2022FY 2023 Revenue: $1.93MFY 2023 Net Income: -$62.60M2023FY 2024 Revenue: $1.38MFY 2024 Net Income: -$83.78M2024FY 2025 Revenue: $1.38MFY 2025 Net Income: -$60.16M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.38M $1.38M $1.93M $1.68M $1.00M $1.29M $2.41M $412K $336K $623K
Research & Development $28.79M $34.89M $27.73M $35.51M $20.31M $33.64M $14.11M $18.15M $33.52M $60.08M
Operating Income -$59.91M -$66.51M -$55.51M -$67.18M -$52.70M -$86.61M -$27.98M -$41.48M -$54.68M -$79.27M
EBITDA -$57.85M -$64.76M -$53.98M -$65.93M -$52.38M -$86.52M -$27.96M -$40.19M -$54.24M -$79.08M
Interest Expense $8.70M $7.77M $5.24M $6.07M $5.01M $8.54M $2.98M $9.87M $5.54M $3.82M
Income Before Tax -$60.70M -$83.78M -- -- -- -- -- -- -- --
Income Tax Expense -$537K $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$60.16M -$83.78M -$62.60M -$105.0M $179.1M -$529.8M -$20.81M -$35.79M -$73.14M -$80.21M
Basic EPS -$0.04 -$0.07 -$0.06 -$0.10 $0.21 -$0.73 -$0.04 -$0.12 -$0.31 -$0.77
Diluted EPS -$0.04 -$0.07 -$0.06 -$0.10 -$0.06 -$0.73 -$0.04 -$0.12 -$0.31 -$0.77
Basic Shares Outstanding 1.46B 1.24B 1.1M 1.0M 873.5K 725.1K 564.2K 440.0M 242.8M 111.1M
Diluted Shares Outstanding 1.46B 1.24B 1.1M 1.0M 1.0M 725.1K 564.2K 440.0M 242.8M 111.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $883K $807K $494K $672K $200K $131K $375K $231K
Research & Development $4.22M $5.71M $4.86M $5.55M $7.45M $7.43M $8.35M $10.52M
Operating Income -$9.94M -$11.61M -$10.90M -$13.50M -$14.32M -$14.78M -$17.31M -$18.50M
EBITDA -$9.15M -$10.83M -$10.13M -$12.78M -$13.92M -$14.28M -$16.91M -$18.06M
Interest Expense $2.60M $1.81M $2.35M $2.65M $2.62M $1.83M $1.60M $2.49M
Net Income -$28.76M -$9.22M -$3.07M $1.39M -$26.83M -$15.38M -$19.34M -$28.22M
Basic EPS -$0.02 -$0.01 $0.00 -- -$0.02 -$0.01 -$0.01 --
Diluted EPS -$0.02 -$0.01 $0.00 -- -$0.02 -$0.01 -$0.01 --
Basic Shares Outstanding 1.71B 1.64B 1.58B -- 1.49B 1.44B 1.36B --
Diluted Shares Outstanding 1.71B 1.64B 1.58B -- 1.49B 1.44B 1.36B --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.04M $2.17M $2.13M $6.96M $15.17M $9.98M $372K $22.22M $117K $6.87M
Cash & Short-Term Investments $3.04M $2.17M $2.13M $6.96M $15.17M $9.98M $372K $22.22M $117K $6.87M
Total Current Assets $5.52M $4.06M $4.12M $9.43M $17.29M $15.51M $3.20M $23.80M $1.40M $7.88M
Property, Plant & Equipment, Net $17.41M $16.20M $17.28M $13.42M $15.03M $1.04M $281K $108K $47.49M $315K
Goodwill $626K $626K $626K $626K $626K $626K $0 -- -- --
Intangible Assets $53.19M $1.29M -- -- -- -- -- -- -- --
Other Non-Current Assets $356K $365K $361K $345K $1.04M $867K $798K $761K $17K $148K
Total Non-Current Assets $75.77M $22.67M $23.74M $21.90M $22.87M $17.39M $7.44M $869K $47.51M $45.02M
Total Assets $81.29M $26.73M $27.86M $31.32M $40.16M $32.90M $10.64M $24.67M $48.91M $52.91M
Accounts Payable -- -- -- -- -- -- -- -- -- $12.38M
Other Current Liabilities $8.35M -- -- -- -- -- -- -- -- --
Total Current Liabilities $91.70M $68.27M $45.20M $126.0M $133.8M $382.4M $44.20M $69.84M $87.68M $76.41M
Long-Term Debt $60.04M $62.68M $40.79M $21.53M $32.40M $14.77M $12.72M $16.80M $31.43M $31.71M
Total Non-Current Liabilities $37.16M $37.43M $29.72M $10.36M $30.38M $13.42M $11.50M $1.99M $8.52M $3.00M
Total Liabilities $128.9M $105.7M $74.92M $136.4M $164.2M $395.8M $55.70M $71.83M $96.20M $79.41M
Total Debt (incl. Leases) $64.83M $67.44M $45.56M $26.25M $37.94M $19.86M $18.03M $16.80M $31.43M $31.71M
Common Stock $1.57M $1.33M $1.18M $1.07M $948K $830K $614K $523K $329K $157K
Retained Earnings -$1.50B -$1.44B -$1.36B -$1.30B -$1.19B -$1.37B -$841.4M -$824.4M -$788.6M --
Accumulated Other Comp. Income -$925K $3.04M $1.54M $3.15M $357K -$1.15M $836K $1.00M -$597K $1.85M
Total Stockholders' Equity -$60.28M -$94.49M -$65.77M -$128.1M -$124.0M -$362.9M -$45.05M -$48.13M -$67.33M -$26.50M
Total Equity -$60.28M -$94.49M -$65.77M -$128.1M -$124.0M -$362.9M -$45.05M -$48.13M -$67.33M -$26.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $725K $595K $1.79M $3.04M $4.56M $4.32M $2.78M $2.17M
Cash & Short-Term Investments $725K $595K $1.79M $3.04M $4.56M $4.32M $2.78M $2.17M
Total Current Assets $2.43M $2.57M $6.20M $5.52M $7.20M $6.16M $4.69M $4.06M
Property, Plant & Equipment, Net $16.07M $16.48M $16.77M $17.41M $16.87M $16.68M $16.29M $16.20M
Goodwill $626K $626K $626K $626K $626K $626K $626K $626K
Intangible Assets $51.78M $51.93M $52.05M $53.19M -- -- -- $1.29M
Other Non-Current Assets $378K $354K $354K $356K $358K $370K $367K $365K
Total Non-Current Assets $73.71M $73.37M $73.85M $75.77M $23.41M $23.39M $22.82M $22.67M
Total Assets $76.14M $75.94M $80.05M $81.29M $30.61M $29.55M $27.50M $26.73M
Other Current Liabilities $6.32M $6.66M $7.32M $8.35M -- -- -- --
Total Current Liabilities $90.94M $73.35M $82.97M $91.70M $87.91M $83.92M $83.06M $68.27M
Long-Term Debt $64.51M $51.97M $59.43M $60.04M $72.20M $64.74M $64.14M $62.68M
Total Non-Current Liabilities $31.50M $37.37M $35.14M $37.16M $37.95M $32.26M $29.28M $37.43M
Total Liabilities $122.4M $110.7M $118.1M $128.9M $125.9M $116.2M $112.3M $105.7M
Total Debt (incl. Leases) $69.83M $56.44M $63.99M $64.83M $77.05M $69.81M $69.00M $67.44M
Common Stock $1.77M $1.68M $1.62M $1.57M $1.52M $1.46M $1.39M $1.33M
Retained Earnings -$1.54B -$1.52B -$1.51B -$1.50B -$1.51B -$1.48B -$1.46B -$1.44B
Accumulated Other Comp. Income -$107K -$246K -$429K -$925K -$1.22M -$1.85M $1.40M $3.04M
Total Stockholders' Equity -$56.70M -$45.17M -$50.54M -$60.28M -$108.6M -$100.4M -$99.48M -$94.49M
Total Equity -$56.70M -$45.17M -$50.54M -$60.28M -$108.6M -$100.4M -$99.48M -$94.49M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$60.20M -$83.80M -$62.80M -$105.0M $179.1M -$529.8M -$20.81M -$35.79M -$73.14M -$80.21M
Depreciation & Amortization $2.06M $1.74M $1.52M $1.25M $324K $87K $21K $1.29M $439K $189K
Stock-Based Compensation $1.21M $3.46M $3.60M $12.30M $15.57M $51.95M $1.82M $14.29M $842K $127K
Operating Cash Flow -$44.76M -$57.02M -$53.64M -$52.77M -$38.30M -$32.09M -$31.86M -$34.59M -$36.49M -$55.65M
Capital Expenditure -$1.50M -$1.01M -$3.44M -$2.90M -$6.01M -$6.61M -$171K $0 -- --
Free Cash Flow -$46.27M -$58.03M -$57.07M -$55.68M -$44.31M -$38.70M -$32.03M -$34.59M -- --
Acquisitions, Net -- -- -- -- -- -$1.53M -- -- -- --
Investing Cash Flow -$1.81M -$1.01M -$3.44M -$2.90M -$6.01M -$8.14M -$360K $45.40M $212K -$4.94M
Common Stock Issued $19.32M $14.22M -- -- -- -- -- -- -- --
Financing Cash Flow $49.33M $56.78M $52.76M $41.97M $48.13M $52.70M $9.95M $7.87M $34.29M $38.31M
Net Change in Cash $865K $49K -$4.84M -$8.20M $5.19M $9.61M -$21.85M $22.11M -$6.75M -$16.18M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$28.80M -$15.40M $3.10M -$121.8M $96.30M -$15.40M -$19.30M -$28.20M
Depreciation & Amortization $792K $774K $771K $728K $400K $500K $400K $437K
Stock-Based Compensation $148K $181K $288K $185K $273K $364K $385K $476K
Operating Cash Flow -$8.76M -$7.17M -$12.51M -$14.76M -$13.89M -$6.69M -$9.42M -$20.18M
Capital Expenditure -$53K -$198K -$129K -$905K -$202K -$304K -$93K -$78K
Free Cash Flow -$8.81M -$7.37M -$12.64M -$15.67M -$14.10M -$6.99M -$9.51M -$20.26M
Investing Cash Flow -$53K -$198K -$129K -$905K -$513K -$304K -$93K -$78K
Common Stock Issued $0 $104K $2.90M $2.02M $4.86M $7.32M $5.12M --
Financing Cash Flow $8.63M $7.37M $9.21M $13.59M $11.56M $12.45M $11.73M $15.94M
Net Change in Cash $130K -$1.19M -$1.25M -$1.52M $244K $1.54M $604K -$764K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -4347.9% -4812.4% -2873.1% -3991.7% -5244.0% -6708.4% -1161.0% -10068.2% -16273.2% -12723.3%
Net Profit Margin -4365.9% -6062.1% -3240.1% -6240.8% 17823.5% -41039.6% -863.6% -8687.9% -21768.8% -12875.4%
Return on Assets (ROA) -74.0% -313.4% -224.7% -335.3% 446.0% -1610.4% -195.5% -145.1% -149.6% -151.6%
Current Ratio 0.06x 0.06x 0.09x 0.07x 0.13x 0.04x 0.07x 0.34x 0.02x 0.10x
Quick Ratio 0.03x 0.03x 0.05x 0.06x 0.11x 0.03x 0.01x 0.32x 0.00x 0.09x
Revenue Growth (YoY) -0.3% -28.5% +14.8% +67.5% -22.2% -46.4% +485.0% +22.6% -46.1% -64.2%
Net Income Growth (YoY) -- -- -- -158.6% -- -- -- -- -- --
EPS Growth (YoY) -- -- -- -147.6% -- -- -- -- -- --
5Y Revenue / Share Growth -99.9% -100.0% +184263.2% +119643.2% +20413.3% +7856.2% +17306.1% -96.2% -100.0% +5183.2%
10Y Revenue / Share Growth -95.8% -95.5% +6912.7% -97.5% +1083656.6% +1193871.5% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -1608.8% -2316.1% -3574.0% -4347.9% -6927.3% -5977.1% -4621.5% -4812.4%
Net Profit Margin -1388.8% -1736.4% -2931.7% -4365.9% -9580.9% -7524.5% -5757.6% -6062.1%
Return on Assets (ROA) -52.1% -49.7% -54.8% -74.0% -293.3% -278.6% -308.3% -313.4%
Current Ratio 0.03x 0.04x 0.07x 0.06x 0.08x 0.07x 0.06x 0.06x
Quick Ratio 0.01x 0.01x 0.02x 0.03x 0.05x 0.05x 0.03x 0.03x
Revenue Growth (YoY) +341.5% +516.0% +31.7% +190.9% -44.0% -74.3% +32.0% -48.1%
Source: SEC EDGAR CompanyFacts (CIK 0001072379) · from December 31, 1997 Data through September 30, 2026 · synced Nov 20, 2026, 05:41 UTC · Open in terminal